Unique fully ambulatory procedure that will transform haemorrhoid care globally.
Patented, fully mobile technology enabling highly convenient & safe treatment in a range of settings.
Evaluation of ongoing treatment quality and outcomes, assurance of efficacy and real world benefit.
Increase the quality and range of services to your patients with a high degree of safety, assurance and profitability.
A portfolio and profit building option for high quality distributors and master distributors.
Partnering with eXroid means we help you grow your business.
eXroid Technology Ltd is one of the first companies to be awarded a King’s Award for Enterprise: Innovation. This accolade represents a milestone for the company as we reach for new heights and strive for better: for our patients, for our partners and for future sufferers.

This prestigious accolade has been awarded to eXroid for their work in developing a highly safe and effective, fully ambulatory treatment for haemorrhoid sufferers, meaning that they are no longer faced with a choice of treatment options that are known to be extremely painful and carry risks of complications, to become symptom free. The eXroid® procedure has advanced the science and understanding of the disease which affects around 9% of the UK population each year to improve the patient pathway for all sufferers.
Read the full announcement here.
After discovering and being successfully treated with this innovative procedure, Graham made it his objective to make it available for all sufferers. His pride in eXroid® receiving this award is only exceeded by the gratitude he has for the team who have worked tirelessly to make this business a success.
eXroid is a ‘life changing’ option for anyone suffering from this common and debilitating condition. It changed my life and it’s been my mission to make it available for everyone else out there who is suffering. The team and capability we have built has been way beyond my expectations. We have an unbelievable culture and we are all committed to improve the clinical science and availability of safe effective care for this condition, across the globe.

Graham Bason – Founder and Commercial Executive Director
The newly renamed King’s Award for Enterprise celebrates outstanding achievement by UK businesses and is internationally recognised.
It was established during Queen Elizabeth II’s reign and conferred in Her Late Majesty’s name, has been renamed to reflect King Charles III’s Accession. Throughout Her Late Majesty’s 70-year reign, Queen Elizabeth II was committed to recognising outstanding work and acts of service by individuals and groups. By attaching His Majesty’s name to these awards, The King has emphasised his desire to continue Queen Elizabeth’s legacy of recognising outstanding businesses.
Since the Award’s inception in 1965 more than 7,000 companies have been awarded. In contrast, nearly 60,000 entries have been received, meaning less than 12% of entries will end up winning an award. The largest category in the awards is the INTERNATIONAL TRADE category, which makes up over half the entires each year. This year just xx (yy%) of awards were given in the category of INNOVATION – with eXroid being one of these.
Since 2020, there have only been 26 winners in the South East of England in the INNOVATION category. We are in good company – with previous winners going on to achieve continued success.
Being part of the eXroid family and seeing us through this momentous milestone has been a personal and professional highlight.
Those who have been through the application process will understand the painstaking effort it takes to complete. This effort is demonstrated across the team in all aspects of our business and as we strive for a better patient pathway for all haemorrhoid sufferers. We are so proud to have been recognised for all the work we have done so far and are even more motivated for the future of eXroid.

Bonney Hallett – Director of Marketing and D2C Services
As a medical device manufacturer, all of our equipment is made and developed in the UK and we are proud to be CE and ISO 13485 accredited by the British Standards Institution BSi.
Our service has been evaluated by the National Institute for Health and Care Excellence (NICE) who have produced two sets of guidelines which accredit the treatment as safe and effective (IPG525 and MIB201). eXroid is a registered and regulated service provider with the Care Quality Commission (CQC) as we strive for the highest levels of care and service standards.
The eXroid service is also PCI DSS compliant, giving both financial assurance and security to our patients when they make their payments with us.

The eXroid® treatment takes 30 minutes or less. Effects can be felt from immediately and no waiting for a referral

The procedure is supported and carried out by the UK's leading specialist consultant surgeons in CQC registered clinics

The eXroid® procedure is low risk, as it requires no anaesthetic, cutting or stitching

Get back to your life straightaway, with no time off work needed after the eXroid® procedure

eXroid® electrotherapy is subject to NICE guidance (IPG525 & MIB201), is rated as Outstanding by the CQC and carries the CE mark
Are you haemorrhoid sufferer wanting the eXroid treatment? Visit our UK patient website here
Privacy & Cookie Policy . Terms of Use . © Copyright 2025 eXroid Technology Ltd. All rights reserved. Company registration number: 07938267
Registered Address: Innovation House, Ramsgate Road, Sandwich, Kent, United Kingdom CT13 9ND.